Latest News

Trump Administration Seeks Public Comment on the Potential Rescheduling of Marijuana

The Trump Administration is currently seeking public comment regarding the potential rescheduling of marijuana and 16 other substances. “The Food and Drug Administration (FDA) is requesting interested persons to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, […]

Latest News

Marijuana Medicine Rescheduled to Schedule V

The United States Drug Enforcement Administration (DEA) has classified Epidiolex, a prescription medicine made from cannabis-derived cannabidiol (CBD), as a Schedule V controlled substance, which is the lowest classification under U.S. law. The Food and Drug Administration (FDA) gave […]